DrugPatentWatch adds Supplementary Protection Certificates
DrugPatentWatch has expanded its global coverage of pharmaceutical patents by adding coverage of Supplementary Protection Certificates.
DrugPatentWatch provides deep knowledge on pharmaceutical drugs and the 90,000 global patents covering them. Uses cases include:
Payers: Formulary and pharmacy & therapeutics (P&T)
Anticipate future budget requirements and proactively identify generic sources
Branded pharmaceutical manufacturers
Assess past successes of patent challengers and elucidate research paths of competitors
Specialty pharmaceuticals and generics
Identify market entry opportunities and inform portfolio management decisions
Buyers, wholesalers, and distributors
Predict branded drug patent expiration, identify generic suppliers, and prevent overstock of branded drugs
Obtain formulation and manufacturing information; identify final formulators, repackagers, and relabellers
The addition of Supplementary Protection Certificates expands coverage of European markets, and helps identify drugs which have these patent extensions.
For more information see www.DrugPatentWatch.com or sign up for a free trial at www.DrugPatentWatch.com/trial.php
Comments are closed.